Valk P et al. |
Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2. |
2000 |
Hematol. J. |
pmid:11920199
|
Ueda N et al. |
Alkaline and acid amidases hydrolyzing anandamide and other N-acylethanolamines. |
2001 |
World Rev Nutr Diet |
pmid:11935959
|
Hansen HS et al. |
When and where are N-acylethanolamine phospholipids and anandamide formed? |
2001 |
World Rev Nutr Diet |
pmid:11935960
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Gardiner SM et al. |
Complex regional haemodynamic effects of anandamide in conscious rats. |
2002 |
Br. J. Pharmacol. |
pmid:11959791
|
Ishii I and Chun J |
Anandamide-induced neuroblastoma cell rounding via the CB1 cannabinoid receptors. |
2002 |
Neuroreport |
pmid:11973452
|
Gerdeman GL et al. |
Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. |
2002 |
Nat. Neurosci. |
pmid:11976704
|
Maccarrone M et al. |
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. |
2002 |
Eur. J. Neurosci. |
pmid:11982628
|
Mukhopadhyay S et al. |
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. |
2002 |
Am. J. Physiol. Heart Circ. Physiol. |
pmid:12003810
|
Romero J et al. |
Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study. |
2002 |
Brain Res. Mol. Brain Res. |
pmid:12008024
|
Maccarrone M et al. |
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. |
2002 |
Biochem. J. |
pmid:12010121
|
Ross RA et al. |
Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12023517
|
Porter AC et al. |
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. |
2002 |
J. Pharmacol. Exp. Ther. |
pmid:12023533
|
Smart D et al. |
'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. |
2002 |
Br. J. Pharmacol. |
pmid:12023948
|
Farquhar-Smith WP et al. |
Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. |
2002 |
Pain |
pmid:12031775
|
Williams CM and Kirkham TC |
Observational analysis of feeding induced by Delta9-THC and anandamide. |
2002 |
Physiol. Behav. |
pmid:12044596
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Mechoulam R |
Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052029
|
Sugiura T et al. |
Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052034
|
Fowler CJ and Jacobsson SO |
Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development? |
2002 Feb-Mar |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12052035
|